NCT02370875View on ClinicalTrials.gov

rTMS and Botulinum Toxin in Benign Essential Blepharospasm

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

May 31, 2017

Study Completion Date

November 30, 2017

Conditions
Benign Essential Blepharospasm
Interventions
DEVICE

Magstim RapidStim2

Application of repetitious transcranial magnetic stimulation (TMS) pulses using Magstim RapidStim2 to a specific brain target at predefined stimulation parameters.

DEVICE

Sham Magstim RapidStim2

Same procedure as real rTMS without stimulating the cerebral cortex.

Trial Locations (1)

32607

Center for Movement Disorders and Neurorestoration, Gainesville

All Listed Sponsors
lead

University of Florida

OTHER

NCT02370875 - rTMS and Botulinum Toxin in Benign Essential Blepharospasm | Biotech Hunter | Biotech Hunter